• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会经济地位在使用 AT(N) 框架时中介了种族差异。

Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework.

机构信息

Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.

Brown School, Washington University in St. Louis, St. Louis, MO, USA.

出版信息

Ann Neurol. 2021 Feb;89(2):254-265. doi: 10.1002/ana.25948. Epub 2020 Nov 7.

DOI:10.1002/ana.25948
PMID:33111990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7903892/
Abstract

OBJECTIVES

African Americans are at greater risk for developing Alzheimer's disease (AD) dementia than non-Hispanic whites. In addition to biological considerations (eg, genetic influences and comorbid disorders), social and environmental factors may increase the risk of AD dementia. This paper (1) assesses neuroimaging biomarkers of amyloid (A), tau (T), and neurodegeneration (N) for potential racial differences and (2) considers mediating effects of socioeconomic status (SES) and measures of small vessel and cardiovascular disease on observed race differences.

METHODS

Imaging measures of AT(N) (amyloid and tau positron emission tomography [PET]) structural magnetic resonance imaging (MRI), and resting state functional connectivity (rs-fc) were collected from African American (n = 131) and white (n = 685) cognitively normal participants age 45 years and older. Measures of small vessel and cardiovascular disease (white matter hyperintensities [WMHs] on MRI, blood pressure, and body mass index [BMI]) and area-based SES were included in mediation analyses.

RESULTS

Compared to white participants, African American participants had greater neurodegeneration, as measured by decreased cortical volumes (Cohen's f = 0.05, p < 0.001). SES mediated the relationship between race and cortical volumes. There were no significant race effects for amyloid, tau, or rs-fc signature.

INTERPRETATION

Modifiable factors, such as differences in social contexts and resources, particularly area-level SES, may contribute to observed racial differences in AD. Future studies should emphasize collection of relevant psychosocial factors in addition to the development of intentional diversity and inclusion efforts to improve the racial/ethnic and socioeconomic representativeness of AD studies. ANN NEUROL 2021;89:254-265.

摘要

目的

非裔美国人患阿尔茨海默病(AD)痴呆的风险高于非西班牙裔白人。除了生物学方面的考虑因素(例如遗传影响和合并症)外,社会和环境因素也可能增加 AD 痴呆的风险。本文(1)评估淀粉样蛋白(A)、tau(T)和神经退行性变(N)的神经影像学生物标志物是否存在潜在的种族差异,(2)考虑社会经济地位(SES)和小血管及心血管疾病测量指标对观察到的种族差异的中介作用。

方法

从年龄在 45 岁及以上的认知正常的非裔美国(n=131)和白人(n=685)参与者中收集了 AT(N)(淀粉样蛋白和 tau 正电子发射断层扫描 [PET])、结构磁共振成像(MRI)和静息状态功能连接(rs-fc)的影像学测量值。小血管和心血管疾病的测量值(MRI 上的白质高信号[WMHs]、血压和体重指数[BMI])和基于面积的 SES 被纳入中介分析。

结果

与白人参与者相比,非裔美国参与者的神经退行性变更严重,表现为皮质体积减少(Cohen's f=0.05,p<0.001)。SES 中介了种族与皮质体积之间的关系。淀粉样蛋白、tau 或 rs-fc 特征均无显著的种族差异。

结论

可改变的因素,如社会环境和资源的差异,特别是基于面积的 SES,可能导致 AD 中观察到的种族差异。未来的研究应除了开发有针对性的多样性和包容性努力外,还应强调收集相关的社会心理因素,以提高 AD 研究的种族/民族和社会经济代表性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/9a6910a66307/nihms-1668375-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/68e0df8f0e4d/nihms-1668375-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/0049de9a6f3e/nihms-1668375-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/3d4752014797/nihms-1668375-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/46f44de6a494/nihms-1668375-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/9a6910a66307/nihms-1668375-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/68e0df8f0e4d/nihms-1668375-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/0049de9a6f3e/nihms-1668375-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/3d4752014797/nihms-1668375-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/46f44de6a494/nihms-1668375-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0890/7903892/9a6910a66307/nihms-1668375-f0005.jpg

相似文献

1
Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework.社会经济地位在使用 AT(N) 框架时中介了种族差异。
Ann Neurol. 2021 Feb;89(2):254-265. doi: 10.1002/ana.25948. Epub 2020 Nov 7.
2
Beta-amyloid and Cortical Thickness Reveal Racial Disparities in Preclinical Alzheimer's Disease.β-淀粉样蛋白与皮质厚度揭示了临床前阿尔茨海默病的种族差异。
Neuroimage Clin. 2017 Sep 21;16:659-667. doi: 10.1016/j.nicl.2017.09.014. eCollection 2017.
3
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
4
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.定量磁敏感图与阿尔茨海默病临床和影像标志物的相关性。
Neuroimage. 2021 Jan 1;224:117433. doi: 10.1016/j.neuroimage.2020.117433. Epub 2020 Oct 6.
5
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.tau蛋白病变和神经退行性变导致阿尔茨海默病的认知障碍。
Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.
6
Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.脑小血管病与阿尔茨海默病风险:系统综述。
Ageing Res Rev. 2018 Nov;47:41-48. doi: 10.1016/j.arr.2018.06.002. Epub 2018 Jun 26.
7
Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.阿尔茨海默病的多发性硬化症的成像生物标志物。
Ann Neurol. 2020 Apr;87(4):556-567. doi: 10.1002/ana.25684. Epub 2020 Feb 8.
8
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.tau 沉积与正常和早期有症状个体中淀粉样-β 积累率的关系。
Brain. 2017 May 1;140(5):1499-1512. doi: 10.1093/brain/awx046.
9
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.基于人群的无痴呆队列中的多模态神经影像生物标志物与轻微认知衰退
J Alzheimers Dis. 2025 Jan;103(2):570-581. doi: 10.1177/13872877241303926. Epub 2024 Dec 19.
10
Subthreshold Amyloid Predicts Tau Deposition in Aging.亚阈值淀粉样蛋白可预测衰老中的 Tau 沉积。
J Neurosci. 2018 May 9;38(19):4482-4489. doi: 10.1523/JNEUROSCI.0485-18.2018. Epub 2018 Apr 23.

引用本文的文献

1
Metabolomic signatures of cognitive function in a type 2 Diabetes-Enriched cohort.2型糖尿病富集队列中认知功能的代谢组学特征
Sci Rep. 2025 Apr 26;15(1):14688. doi: 10.1038/s41598-025-99606-4.
2
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease.阿尔茨海默病神经精神症状的最新进展与未来展望
Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.
3
Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer's disease in a diverse cohort: MESA.多队列研究中的小血管疾病和阿尔茨海默病的血浆及神经影像学生物标志物:多民族动脉粥样硬化研究(MESA)

本文引用的文献

1
Addressing Health Disparities Among Minority Populations: Why Clinical Trial Recruitment Is Not Enough.解决少数族裔人群中的健康差距问题:为何临床试验招募工作还不够。
JAMA Neurol. 2020 Sep 1;77(9):1063-1064. doi: 10.1001/jamaneurol.2020.1614.
2
Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology.社区水平劣势与阿尔茨海默病神经病理学的关联。
JAMA Netw Open. 2020 Jun 1;3(6):e207559. doi: 10.1001/jamanetworkopen.2020.7559.
3
Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume.
medRxiv. 2025 Feb 14:2025.02.11.25322109. doi: 10.1101/2025.02.11.25322109.
4
Integrating Machine Learning and Environmental and Genetic Risk Factors for the Early Detection of Preclinical Alzheimer's Disease.整合机器学习与环境和遗传风险因素用于临床前阿尔茨海默病的早期检测
J Gerontol B Psychol Sci Soc Sci. 2025 Jun 10;80(7). doi: 10.1093/geronb/gbaf023.
5
Cross-Sectional Comparison of Structural MRI Markers of Impairment in a Diverse Cohort of Older Adults.不同老年人群体中损伤的结构磁共振成像标志物的横断面比较
Hum Brain Mapp. 2025 Feb 1;46(2):e70133. doi: 10.1002/hbm.70133.
6
Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognition.神经影像学和生物流体生物标志物在认知谱中老年人群体中的种族和民族差异。
Ageing Res Rev. 2024 Nov;101:102507. doi: 10.1016/j.arr.2024.102507. Epub 2024 Sep 19.
7
Cross-ancestry genome-wide association studies of brain imaging phenotypes.跨种族脑影像表型的全基因组关联研究。
Nat Genet. 2024 Jun;56(6):1110-1120. doi: 10.1038/s41588-024-01766-y. Epub 2024 May 29.
8
Recruiting a prospective community cohort to study Alzheimer's disease and structural and social determinants of health among adults racialized as Black: The ARCHES cohort.招募一个前瞻性社区队列,以研究阿尔茨海默病以及被归类为黑人的成年人的健康结构和社会决定因素:ARCHES队列。
Alzheimers Dement (N Y). 2024 May 16;10(2):e12473. doi: 10.1002/trc2.12473. eCollection 2024 Apr-Jun.
9
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.种族和民族差异对临床前阿尔茨海默病试验中血浆生物标志物入选的影响。
Alzheimers Dement. 2024 Jun;20(6):3827-3838. doi: 10.1002/alz.13803. Epub 2024 Apr 17.
10
White matter hyperintensities in diverse populations: A systematic review of literature in the United States.不同人群中的白质高信号:美国文献的系统综述
Cereb Circ Cogn Behav. 2024 Jan 14;6:100204. doi: 10.1016/j.cccb.2024.100204. eCollection 2024.
社区劣势与大脑和海马体体积的关联。
JAMA Neurol. 2020 Apr 1;77(4):451-460. doi: 10.1001/jamaneurol.2019.4501.
4
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.评估阿尔茨海默病生物标志物的种族差异。
JAMA Neurol. 2019 Mar 1;76(3):264-273. doi: 10.1001/jamaneurol.2018.4249.
5
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.阿尔茨海默病及相关痴呆症的种族和民族差异视角:更新与当前急需领域。
Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13.
6
Progress and future challenges in aging and diversity research in the United States.美国老龄化与多样性研究的进展和未来挑战。
Alzheimers Dement. 2019 Jul;15(7):995-1003. doi: 10.1016/j.jalz.2018.07.221. Epub 2018 Sep 19.
7
Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.种族改变了认知与阿尔茨海默病脑脊液生物标志物之间的关系。
Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.
8
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.散发性晚发性阿尔茨海默病的多基因风险评分揭示了与家族性和早发性形式的共同结构。
Alzheimers Dement. 2018 Feb;14(2):205-214. doi: 10.1016/j.jalz.2017.08.013. Epub 2017 Sep 21.
9
Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia.美国黑人和白人的认知老化:认知、认知下降和阿尔茨海默病痴呆症的发病率。
Epidemiology. 2018 Jan;29(1):151-159. doi: 10.1097/EDE.0000000000000747.
10
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.AV-1451 正电子发射断层扫描(PET)对阿尔茨海默病临床前tau 病理学的成像:定义一个综合指标。
Neuroimage. 2017 Nov 1;161:171-178. doi: 10.1016/j.neuroimage.2017.07.050. Epub 2017 Jul 26.